MONSANTO POSITION
|
INDIVIDUAL
|
FEDERAL POSITION
|
---|---|---|
Senior Vice President for Clinical Affairs at G.D. Searle and Co. (merged with Monsanto)
|
Michael A. Friedman
|
Acting Commissioner of the FDA
|
Consultant to Searle’s Public Relation Firm (merged with Monsanto)
|
Arthur Hull Hayes
|
Previously FDA Commissioner
|
Top Monsanto Scientist, oversaw approval of rBGH
|
Margaret Miller
|
Appointed Deputy Director of FDA, 1991
|
Worked on Monsanto-funded rBGH in connection with Cornell University
|
Suzanne Sechen
|
FDA Reviewer on Scientific Data
|
Attorney for Monsanto for 7 years, previous Head of Monsanto Washington D.C. Office
|
Michael Taylor
|
Former FDA Deputy Commision for Policy. In 2010 appointed Senior Advisor to FDA Commissioner
|
Former Monsanto Lawyer
|
Clarence Thomas
|
Appointed to U.S. Supreme Court in 1991
|
Served on Board of Directors at Calgene, a Monsanto Biotech Subsidiary
|
Anne Veneman
|
Appointed head of USDA in 2001
|
Retired Senior Vice President for Public Policy at Monsanto
|
Dr. Virginia Weldon
|
Previously, member of FDA’s Metabolism and Endocrine Advisory Committee
|
Vice President, Public and Government Affairs
|
Linda Fisher
|
Deputy Administration EPA
|
Manager, New Technologies
|
Linda Watrud
|
USDA, EPA
|
Director, Monsanto Danforth Center
|
Roger Beachy
|
Director USDA, NIFA
|
Fini
14 years ago
No comments:
Post a Comment